ANTHEM.NS Overview

Company Profile

Related stocks

BIOCON.NS • India

BIOCON LIMITED.

349.4 INR

5.91B USD 1Y +0.3%

002252.SZ • China

SHANGHAI RAAS

5.06 CNY

4.99B USD 1Y -25.4%

688336.SS • China

SUNSHINE GUOJIAN PHARMACEUTICAL

38.1 CNY

5.11B USD 1Y +4.2%

603392.SS • China

BEIJING WANTAI BIOLOGICAL PHARM

26.96 CNY

5.1B USD 1Y -53.6%

300122.SZ • China

ZHIFEI-BIOL

13.7 CNY

4.91B USD 1Y -34.6%

688180.SS • China

SHANGHAI JUNSHI BIOSCIENCES CO

33.83 CNY

5.19B USD 1Y -17.6%

1530.HK • China

3SBIO

15.07 HKD

4.76B USD 1Y -47.3%

9995.HK • China

REMEGEN

70.4 HKD

5.34B USD 1Y -33.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

Max Drawdown (3Y)

Sharpe Ratio (3Y)

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 85.0 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections